PeptideDB

VU0364770 hydrochloride 1414842-70-8

VU0364770 hydrochloride 1414842-70-8

CAS No.: 1414842-70-8

VU0364770HCl is a potent and specific mGlu4 PAM (positive allosteric modulator). VU0346770HCl has EC50 of 290 nM and 1.1
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

VU0364770 HCl is a potent and specific mGlu4 PAM (positive allosteric modulator). VU0346770 HCl has EC50 of 290 nM and 1.1 μM for rat mGlu4 and human mGlu4 receptors, respectively. VU0364770 HCl has antagonistic activity against mGlu5 with EC50 of 17.9 μM, and VU0364770 HCl has positive allosteric modulating activity against mGlu6 with EC50 of 6.8 μM. VU0364770 HCl is also active against MAO, with Kis of 8.5 and 0.72 μM for human MAO-A and MAO-B, respectively.

Physicochemical Properties


Molecular Formula C12H10CL2N2O
Molecular Weight 269.1266
Exact Mass 268.017
CAS # 1414842-70-8
Related CAS # VU0364770;61350-00-3
PubChem CID 56587900
Appearance Light yellow to yellow solid powder
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 2
Heavy Atom Count 17
Complexity 247
Defined Atom Stereocenter Count 0
SMILES

ClC1=C([H])C([H])=C([H])C(=C1[H])N([H])C(C1=C([H])C([H])=C([H])C([H])=N1)=O.Cl[H]

InChi Key CZNNJOSFWZBQKH-UHFFFAOYSA-N
InChi Code

InChI=1S/C12H9ClN2O.ClH/c13-9-4-3-5-10(8-9)15-12(16)11-6-1-2-7-14-11;/h1-8H,(H,15,16);1H
Chemical Name

N-(3-chlorophenyl)pyridine-2-carboxamide;hydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Rat mGlu4 290 nM (EC50) Human mGlu4 1.1 μM (EC50) mGlu6 6.8 μM (EC50) mGlu5 17.9 μM (EC50)
References

[1]. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. J Pharmacol Exp Ther.


Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (371.57 mM)
H2O: < 0.1 mg/mL
Solubility (In Vivo) Solubility in Formulation 1: ≥ 5 mg/mL (18.58 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 5 mg/mL (18.58 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.7157 mL 18.5784 mL 37.1568 mL
5 mM 0.7431 mL 3.7157 mL 7.4314 mL
10 mM 0.3716 mL 1.8578 mL 3.7157 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.